Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia

E-ISSN： 1873-5576|16|8|659-668

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.8, 2016-09, pp. : 659-668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD38 in Chronic Lymphocytic Leukemia: From Bench to Bedside?

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 503-507

Bentham Science Publishers

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig Lamanna Nicole Weiss Mark A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite

Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1313-1327

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-10 ,pp. : 689-700

Bentham Science Publishers

Access to resources Recommend Favorite

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth Kahl Brad Steven

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite